Pharmaceutical executives are calling on President-elect Donald Trump to appoint someone with a medical background to serve as chief of the U.S. Food and Drug Administration, and ensure the agency continues evaluating the effectiveness of new therapies, reports Bloomberg.
Supply Chain
As part of a national plan to fight drug abuse, Deerfield, Ill.-based Walgreens has made naloxone, a lifesaving opioid antidote, available without a prescription in more than 240 of its Arizona pharmacies in accordance with state pharmacy regulations.
The FDA issued a safety alert Jan. 14 regarding Physio-Control's LIFEPAK 1000 defibrillator after reported incidents of the device shutting down suddenly during treatment.
San Francisco-based McKesson Corp. will pay $150 million — a record high amount — as part of a Controlled Substances Act civil penalty settlement to resolve allegations it failed to report suspicious orders of painkillers.
Here are the five latest drugs and medical devices approved by the Food and Drug Administration.
Advertisement
Israel-based Teva Pharmaceutical Industries earned approval from the Food and Drug Administration for its abuse-deterrent painkiller Vantrelatmer.
The Food and Drug Administration approved the first generic version of Jazz Pharmaceutical's drug Xyrem to treat patients with narcolepsy.
Andrew Left, a well-known short seller at Citron Research, predicts generic drug firm Lannett will be the first drugmaker to go bankrupt amid ongoing drug pricing scrutiny, according to a report released Tuesday.
When asked how the drug industry should react to President-elect Donald Trump's vow to "bring down drug prices," Pfizer CEO Ian Read had an unlikely response: Raise drug prices.
Cambridge, Mass.-based Biogen entered a licensing agreement with Forward Pharma for the Danish drugmaker's multiple sclerosis treatments.